INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS SHAREHOLDERS VOTE "FOR" OPSENS INC. PLAN OF ARRANGEMENT WITH HAEMONETICS CORPORATION

All amounts in this press release are in Canadian dollars.

QUÉBEC CITY, Nov. 13, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX:OPS.TO) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, is pleased to announce that Institutional Shareholder Services Inc. ("ISS") has recommended holders (the "Shareholders") of common shares in the capital of OpSens (the "Shares") vote FOR the previously announced indirect acquisition by Haemonetics Corporation ("Haemonetics") (NYSE:HAE) of all of the issued and outstanding Shares of OpSens for $2.90 in cash per Share, pursuant to a statutory plan of arrangement (the "Arrangement") under the Business Corporations Act (Québec). The Arrangement is to be voted on at the special meeting of Shareholders to be held on December 1, 2023 (the "Meeting").